Life and death with an autoimmune disease
There are now more than 100 autoimmune diseases, in which the immune system that would normally help a person fight off disease instead mistakenly attacks healthy tissue and does damage to the body.
According to the National Institutes of Health, up to 23.5 million Americans suffer from an autoimmune disease, and the incidence of many of the conditions is rising for reasons that aren't entirely clear. And the list of potentially fatal autoimmune diseases, or those that can shorten life span, is long. These conditions include everything from rheumatoid arthritis, which causes pain and swelling in the joints and raises the risk for life-threatening cardiovascular disease, to lupus, a chronic disease that can cause inflammation in any part of the body.
"Almost all autoimmune diseases decrease life expectancy," says Dr. Betty Diamond, director of the Institute of Molecular Medicine at the Feinstein Institutes for Medical Research at Northwell Health in Manhasset, New York. One notable exception is hypothyroidism, or underactive thyroid, she says.
Treatment advancements mean many with autoimmune diseases now live longer.
While disease severity varies, improvements in treatment have greatly bolstered life expectancy and improved quality of life for many with autoimmune conditions. Therapeutic advances include biologic drugs that suppress the immune system activity -- or overactivity -- that cause myriad health problems for those with autoimmune diseases such as lupus and multiple sclerosis.
Frequently, as with other disease prevention and management, a combination of lifestyle improvements -- like eating well, exercising regularly and getting adequate sleep -- and medical management are recommended. "The most important thing is to find a physician who's knowledgeable and experienced and with whom you work well, and together work out a treatment regimen that works for you," Diamond says.
Autoimmune diseases may impact mortality in a couple ways: First, more common autoimmune diseases like rheumatoid arthritis and Type 1 diabetes can have an impact on the lives of a greater number of people. And second, "There are autoimmune diseases that have a very high rate of mortality but are very rare," says Dr. Virginia Pascual, director of the Gale and Ira Drukier Institute for Children's Health at Weill Cornell Medicine in New York City. One example of that, she notes, is autoimmune myocarditis, a rare autoimmune disease characterized by inflammation of the heart muscle.
Myocarditis is often diagnosed in people their 20s to 40s, and symptoms like abnormal heart beat, chest pain, shortness of breath, fatigue and fever can come on suddenly and without warning. The condition is underdiagnosed and may cause sudden death.
So with possible heart attack symptoms, it's important to seek medical attention immediately for possible symptoms of the disease. When it is diagnosed, drugs that suppress the immune system may be used to treat autoimmune myocardititis.
Nearly 1 million people in the U.S. are living with multiple sclerosis, according to the National Multiple Sclerosis Society. This autoimmune disorder affecting the brain and spinal cord results from the immune system attacking a protective layer around the nerves called the myelin sheath, which can cause a range of problems. These include difficulty with coordination and balance to thinking and memory issues.
Treatment improvements continue to inch life expectancy for those with MS closer to what's typical for people without the neurologic disorder. However, research published in the journal Neurology suggests people with MS live seven years less, on average; those with MS had a median age of survival of about age 76 compared to 83 for a matched general population, according to the 2015 study.
Among other treatment options, drugs therapies targeting B cells -- a type of white blood cells, cells used by body's immune system -- have shown promise. "B cell depletion therapy has been phenomenal for many patients with multiple sclerosis, and is now standard of care, which it certainly wasn't some years ago," Diamond says.
In addition to treating the autoimmune disorders, clinicians have to be mindful of treating other health problems caused by or related to the autoimmune disorders. For example, the most common type of lupus, systemic lupus erythematosus, causes widespread inflammation and impacts organs like the kidneys (a form called lupus nephritis). So improved treatment of kidney disease, including the availability of kidneys for transplant, has helped improve the outlook for many with lupus.
Therapies that suppress the immune system also put patients at a higher risk of infection, a cause of death in some patients with lupus. So improved treatment of infections -- including, as Diamond notes, having better antibiotics for some of infectious complications of treating lupus -- has also positively impacted survival rates for people with lupus.
As with other autoimmune conditions, various factors impact life expectancy for people with lupus, including, for reasons not fully understood, ethnicity. "Lupus mortality is increased in this country in African-Americans, in Hispanic populations, in Asians and is decreased in Caucasians," Pascual says.
Type 1 diabetes
Commonly diagnosed in kids, Type 1 diabetes is an autoimmune disease in which the immune system attacks the pancreas so that it can't make the insulin needed to properly control blood sugar.
Those with diabetes that's well-controlled can live long, full lives and have good quality of life. However, particularly if it isn't well-managed, Type 1 and other forms of diabetes (which aren't autoimmune diseases) can cause a variety of serious complications. Those can include kidney and heart disease, eye disease, or diabetic retinopathy, and nerve problems.
Type 1 diabetes is managed with insulin -- to keep blood sugar within a healthy range -- rather than suppressing the immune system. Exemplifying the impact of lifestyle, proper management of Type 1 diabetes means also carefully considering diet, as well as exercising regularly. That includes controlling carbohydrate consumption and evenly spreading carbs across the day with meals and snacks.
Vasculitis -- inflammation of the blood vessels, which is often caused by autoimmune disorders -- also decreases life expectancy, notes Dr. Ignacio Sanz, chief of the division of rheumatology at Emory University School of Medicine, and director of the Lowance Center for Human Immunology at Emory University and Children's Healthcare of Atlanta.
Treatment involves using medications like corticosteroids to control inflammation as well as addressing any underlying disease. Biologic therapies may be used to deal with immune system issues that contribute to the condition.
To prevent infections that can occur when immunosuppressive treatments are used for any autoimmune disorder, patients are encouraged to stay up to date on vaccinations. That includes getting vaccinated to prevent the flu, shingles and pneumonia, as recommended by a doctor. Vaccination should be part of the standard of care with autoimmune diseases, Sanz says.
The joint disease -- which affects up to 1% of the population, predominantly women -- can raise the risk for heart disease and lung disease. Based on research to date, having RA may decrease life expectancy by a decade or more.
RA is one of a number of autoimmune disorders called rheumatic diseases, or musculoskeletal conditions marked by inflammation. Most rheumatic diseases have a decreased life expectancy and increased mortality, Sanz says. "That is very well-documented for rheumatoid arthritis, it's well-documented for lupus (and) it's clear for vasculitis."
However, as with other autoimmune diseases, life span varies greatly with RA by the individual, and proper management of the disease can improve a person's outlook. Treatment often includes the use of immunosuppressive anti-rheumatic drugs (DMARDs) and self-care for arthritis symptoms such as using a heating pad and pain relievers to ease joint discomfort.
Just as rheumatoid arthritis can impact health well beyond inflaming joints, psoriasis is more than a skin disease. The autoimmune disorder is also associated with other serious issues, including an increased risk of diabetes, depression and heart disease.
As a result, depending on the severity of psoriasis, it may affect life expectancy and raise mortality risk. For that reason, experts say, patients and their doctors should discuss not only topical treatment to address scaly patches of skin, but if and when immunosuppressive therapy might be warranted.
Some autoimmune conditions that may affect life expectancy:
-- Autoimmune myocarditis.
-- Multiple sclerosis.
-- Type 1 diabetes.
-- Rheumatoid arthrtis.
Read more from the original source:
- UCSD Researchers Discover Carbohydrate In Lungs That COVID-19 Uses To Infect - KPBS - September 18th, 2020
- New article shows how science could reveal racism's real impact on the body and brain - The South End - September 18th, 2020
- Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications. - Physician's Weekly - September 18th, 2020
- Highly Revered Cardiologist Dr. James T. Willerson Passes Away at St. Luke's in Houston - PaperCity Magazine - September 18th, 2020
- Why This Genomics ETF Is a Long-Term Winner - ETF Trends - September 18th, 2020
- BIS Research Report Highlights the Global Precision Medicine Market to Reach $278.61 Billion by 2030 - PRNewswire - September 18th, 2020
- UK research getting to bottom of COVID clots - ABC 36 News - WTVQ - September 18th, 2020
- Jumpcode Genomics Exits Stealth Mode, Unveils Technology that Addresses the 'Needle in the Haystack' Problem of Molecular Biology - Bio-IT World - September 18th, 2020
- HTG Molecular Diagnostics Inc. [HTGM] Is Currently 1.85 above its 200 Period Moving Avg: What Dose This Mean? - The DBT News - September 18th, 2020
- Scientists outraged by White House appointees' meddling with coronavirus information: 'Outright egregious' - USA TODAY - September 18th, 2020
- Synthekine Launches with $82 Million Series A Financing to Advance Pipeline of Engineered Cytokine Therapeutics Optimized for Cancer and Autoimmune... - September 18th, 2020
- 2bPrecise Wins Industry Innovation Award - Bio-IT World - September 18th, 2020
- Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2 Inhibitor | Small... - September 4th, 2020
- No pain, still gain (of function): the relation between sensory profiles and the presence or absence of self-reported pain in a large multicenter... - September 4th, 2020
- Use of plasma therapy shouldn't be considered as standard of care for Covid-19, NIH disputes Trump endorsement - MEAWW - September 4th, 2020
- Special Scientist, Biobank Information Management Systems job with UNIVERSITY OF CYPRUS | 223742 - Times Higher Education (THE) - September 4th, 2020
- What's Happening Week of Sept. 6 | News | thealmanac.net - The Almanac - September 4th, 2020
- Sep 4 Getting real with CBD- a veterinary surgeon's perspective - Jill Lopez - September 4th, 2020
- Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria - Business Wire - September 4th, 2020
- A unique molecule present in the venom of Honeybee can Kill Breast Cancer Cells, a study hints - News Landed - September 4th, 2020
- Oncology Molecular Diagnostics Market | 2020 Global Industry Analysis By Size, Share, And Growth Factors With Forecast To 2026 - The Daily Chronicle - September 4th, 2020
- Gene therapy research for HIV awarded $14.6 million NIH grant - USC News - September 4th, 2020
- Professor on using AI to detect medical errors, the future of AI in medicine - The Stanford Daily - August 28th, 2020
- Professor/Associate Professor in Medicine Obesity and Metabolism job with NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY - NTNU | 223116 - Times... - August 28th, 2020
- Medical Bioinformatics Market shares and strategies of key players - BioSpace - August 28th, 2020
- Understanding Neurodegenerative Disease Such as Alzheimers and ALS by Examining the Overlap of microRNAs, Oxidative Stress, and Mitochondria... - August 28th, 2020
- World-leading Virologists to Speak at COVID-19 International Conference - PRNewswire - August 28th, 2020
- COVID-19 & Healthcare: Personalized Medicine is the Future - The National Law Review - August 28th, 2020
- Identifying emerging diseases focus of new international collaboration - Washington University School of Medicine in St. Louis - August 28th, 2020
- Impact of exogenous antithrombin on low molecular weight heparin anti-Xa activity assays in a pediatric and young adult leukemia and lymphoma cohort... - August 28th, 2020
- 4D Molecular Therapeutics Appoints Susannah Gray to Board of Directors - BioSpace - August 28th, 2020
- Oncocyte Announces Addition of Experienced Healthcare Executive, Jennifer Carter, MD, MPH, MBA to Board of Directors - GlobeNewswire - August 28th, 2020
- STRUCTURAL BIOLOGY AND MOLECULAR MODELING TECHNIQUES MARKET PREDICTED TO ACCELERATE THE GROWTH BY 2017-2025 - Scientect - August 28th, 2020
- HTG Molecular Diagnostics Inc. (HTGM) market price of $0.37 offers the impression of an exciting value play - The InvestChronicle - August 28th, 2020
- Commitment to Education and Mentoring: How Memorial Sloan Kettering Continued Summer Internships During the Pandemic - On Cancer - Memorial Sloan... - August 24th, 2020
- We Should Call Traditional Medicine The Original Medicine: Dr Apurve Mehra - Outlook India - August 24th, 2020
- George Mason scientists help with saliva test that could be a game-changer for tracking COVID-19 in US - 13newsnow.com WVEC - August 24th, 2020
- Global Bioinformatics Market Explosive Growth And Key Trends Analysis | Eminent Players Are Agilent Technologies, Inc. (US), QIAGEN (Netherlands), BGI... - August 24th, 2020
- Students connect medical history to today's practice The Daily Evergreen - The Daily Evergreen - August 24th, 2020
- Dr. Stephen Robbins appointed Director of the Lady Davis Institute at the Jewish General Hospital - McGill Reporter - August 24th, 2020
- Treating COVID-19: Bipolar drug shows promise and other hopeful findings - Medical News Today - August 24th, 2020
- Piezoceramics Bring Precision and Reliability to Medical Technologies - Novus Light Technologies Today - August 24th, 2020
- Dr. Torry Tucker Receives Outstanding Teaching Award - East Texas Review - August 24th, 2020
- Companion Diagnostic, Targeted Therapy Approvals Rise in Tandem - OncLive - August 24th, 2020
- NeuBase Therapeutic's CEO, Dietrich A. Stephan, Ph.D., to Present at Tribe Public's Presentation and Q&A Webinar Event on August 26, 2020 - BioSpace - August 24th, 2020
- Unusual four-stranded configuration of DNA plays a vital role in breast cancer - Tech Explorist - August 10th, 2020
- T-knife Completes 66 Million Series A Financing to Develop Next-Generation T-Cell Therapies - GlobeNewswire - August 10th, 2020
- New study published in the Journal of the National Cancer Institute concludes that Epi proColon is the test of choice for the millions of individuals... - August 10th, 2020
- Local researchers tracking COVID-19 through antibody testing project - TribDem.com - August 7th, 2020
- Suppression of c-Met-Overexpressing Tumors by a Novel c-Met/CD3 Bispec | DDDT - Dove Medical Press - August 7th, 2020
- Targeted Protein Degradation Represents a Promising Therapeutic Strategy - Genetic Engineering & Biotechnology News - August 6th, 2020
- They discover that this mineral protects against the coronavirus - Checkersaga - August 6th, 2020
- Breaking News: Todos Medical Appoints Dr. Jorge Leon as Consulting Chief Medical and Scientific Officer of Infectious Disease and Oncology -... - August 6th, 2020
- Myriad to Announce Fiscal Fourth-Quarter and Full Fiscal Year 2020 Financial Results on August 13, 2020 - GlobeNewswire - August 6th, 2020
- Large International Study Pinpoints Impact of TP53 Gene Mutations on Blood Cancer Severity - On Cancer - Memorial Sloan Kettering - August 6th, 2020
- Cannabinoid therapies aim to address unmet medical needs - Health Europa - August 6th, 2020
- HTG Molecular Diagnostics to Announce Second Quarter 2020 Financial Results and Host Conference Call on Tuesday, August 11 - Stockhouse - August 6th, 2020
- Reusable face mask capable of inactivating virus launched in Portugal - Fall River Herald News - August 3rd, 2020
- Dr. Khong on Endocrine Therapy Combinations in ER+/HER2- Breast Cancer - OncLive - August 3rd, 2020
- Delivering on the promise of precision cancer medicine and why it matters even more during a pandemic - MedCity News - August 3rd, 2020
- There Is Little Evidence That Mass Transit Poses a Risk of Coronavirus Outbreaks - Scientific American - August 3rd, 2020
- Neanderthals May Have Been More Sensitive to Pain Than Most Humans - Smithsonian Magazine - August 3rd, 2020
- A breakthrough: Stem cell therapy cures Covid-19 The Manila Times - The Manila Times - August 3rd, 2020
- mTOR and the Science of Aging and Chronic Disease - The Doctor Weighs In - August 3rd, 2020
- A shift in brain glucose metabolism may help explain women's increased risk of Alzheimer's disease - National Institute on Aging - August 3rd, 2020
- Global Bioinformatics Service Market Report COVID-19 Outbreak Development Trends, Threats, Growth Opportunities and Competitive Landscape in 2024 -... - August 3rd, 2020
- Photopharmacology Switching Drugs On and Off With Light - Technology Networks - August 3rd, 2020
- How AI is uncovering the 'dark matter of nutrition' - World Economic Forum - August 3rd, 2020
- Spiritual Forces May Be Behind the Difficulties You Face, Yet Cannot Explain - Benzinga - August 1st, 2020
- Finding the road to peace - The New Indian Express - August 1st, 2020
- Cardinal Parolin to visit Ars and Lourdes in August - Vatican News - August 1st, 2020
- Indian players are rising to the occasion offering users familiarity of homegrown social networks - The Financial Express - August 1st, 2020
- Lexington gym owner promotes mind, body and spiritual wellness - ABC 36 News - WTVQ - August 1st, 2020
- Rural Development Minister: Eid-Ul-Adha brings spiritual renewal - Loop News Trinidad and Tobago - August 1st, 2020
- Sparano Shares Progress Made in the Molecular Guided Management of Breast Cancer - OncLive - August 1st, 2020
- Stress-sensing Molecule May Be Potential Therapeutic Target in ALS - ALS News Today - August 1st, 2020
- Electroceuticals/Bioelectric Medicine Market to Witness Tremendous Growth in Coming Years || Leading Players - BioElectronics Corporation, SetPoint... - August 1st, 2020
- Digong forgot to mention the cure for Covid-19 The Manila Times - The Manila Times - August 1st, 2020
- Coronavirus testing hits a wall: Where do we go from here? - MedTech Dive - August 1st, 2020
- miRagen, Investigators from Goethe University and University Hospital Frankfurt and Servier Publish MRG-110 Phase 1 Pharmacodynamic Biomarker Data in... - July 31st, 2020